KOSDAQ · Healthcare · ₩506B
₩7,140-6.79%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 14.7% · as of 26.10.27
Among 37 신약 개발 peers
Quarterly Revenue Growth
“임상 진전은 이어지지만 아직 연구 성과를 확인하는 구간이에요.”
In the company's words · 2026 2분기 filing